Initial U.S. Supreme Court Hearing Mixed on Teva’s Pharmaceuticals Patent Protection

– Leading Israeli Pharmaceutical company Teva has mixed results in its initial U.S. Supreme Court hearing over the possible loss of patent protection for Copaxone, a multiple sclerosis drug that accounts More...